S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:TRHC

Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News

$2.30
-0.37 (-13.86%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$2.16
$2.75
50-Day Range
$2.30
$5.96
52-Week Range
$2.16
$53.38
Volume
1.15 million shs
Average Volume
758,619 shs
Market Capitalization
$59.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.55
30 days | 90 days | 365 days | Advanced Chart
Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

Tabula Rasa HealthCare logo

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,602
Year Founded
N/A

Sales & Book Value

Annual Sales
$331.26 million
Cash Flow
$0.21 per share
Book Value
$1.40 per share

Profitability

Net Income
$-79.06 million
Pretax Margin
-26.53%

Debt

Price-To-Earnings

Miscellaneous

Free Float
23,212,000
Market Cap
$59.45 million
Optionable
Optionable

Company Calendar

Last Earnings
2/24/2022
Today
5/22/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.44 out of 5 stars

Medical Sector

179th out of 1,416 stocks

Business Services, Not Elsewhere Classified Industry

39th out of 141 stocks

Analyst Opinion: 3.1Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 0.6 5 -4 -3 -2 -1 -













Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

Is Tabula Rasa HealthCare a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Tabula Rasa HealthCare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View analyst ratings for Tabula Rasa HealthCare
or view top-rated stocks.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Tabula Rasa HealthCare
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings results on Thursday, February, 24th. The company reported ($0.49) earnings per share for the quarter. The business earned $85.69 million during the quarter, compared to analysts' expectations of $85.19 million. Tabula Rasa HealthCare had a negative net margin of 27.28% and a negative trailing twelve-month return on equity of 84.40%. Tabula Rasa HealthCare's revenue was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.53) EPS.
View Tabula Rasa HealthCare's earnings history
.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its second quarter 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $66.00 million-$69.00 million, compared to the consensus revenue estimate of $91.40 million.

What price target have analysts set for TRHC?

7 analysts have issued 1-year target prices for Tabula Rasa HealthCare's shares. Their forecasts range from $11.00 to $24.00. On average, they anticipate Tabula Rasa HealthCare's share price to reach $15.71 in the next year. This suggests a possible upside of 583.2% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
or view top-rated stocks among Wall Street analysts.

Who are Tabula Rasa HealthCare's key executives?
Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D., Co-Founder, Chairman & CEO (Age 72, Pay $542.93k)
  • Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 53, Pay $419.45k)
  • Mr. Brian W. Adams, Co-Pres & Sec. (Age 40, Pay $407.83k) (LinkedIn Profile)
  • Mr. Michael Greenhalgh, Chief Operating Officer (Age 60, Pay $407.53k) (LinkedIn Profile)
  • Mr. Thomas J. Cancro C.F.A., CPA, Chief Financial Officer (Age 54)
  • Ms. Andrea Carolan Speers M.S., Corp. Controller & Chief Accounting Officer (Age 41)
  • Mr. Bob Sullivan M.S., Chief Technology Officer
  • Dr. Jacques Turgeon B.Pharm., Ph.D., Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute (Age 62)
  • Mr. Phillip W. Heath MS, Chief Admin. Officer (Age 56)
  • Mr. Frank Sparacino C.F.A., CPA, Sr. VP of Investor Relations & Corp. Devel.
What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare CEO Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among Tabula Rasa HealthCare's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), (CGC), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.88%), State Street Corp (3.27%), Baillie Gifford & Co. (3.22%), Engineers Gate Manager LP (1.21%), Walleye Capital LLC (1.06%) and JPMorgan Chase & Co. (0.91%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Jan Berger, Michael Greenhalgh, Orsula V Knowlton, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends for Tabula Rasa HealthCare
.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Citigroup Inc., Bank of New York Mellon Corp, Invesco Ltd., Vanguard Group Inc., Exchange Traded Concepts LLC, Simplex Trading LLC, and Rhumbline Advisers. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Michael Greenhalgh, Orsula V Knowlton, and Samira Beckwith.
View insider buying and selling activity for Tabula Rasa HealthCare
or view top insider-selling stocks.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was bought by a variety of institutional investors in the last quarter, including Engineers Gate Manager LP, JPMorgan Chase & Co., Federated Hermes Inc., Walleye Capital LLC, PDT Partners LLC, Connor Clark & Lunn Investment Management Ltd., Renaissance Technologies LLC, and Quantbot Technologies LP. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Dennis Helling, Gordon Tunstall, Jan Berger, and Michael Greenhalgh.
View insider buying and selling activity for Tabula Rasa HealthCare
or or view top insider-buying stocks.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $2.30.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare has a market capitalization of $59.46 million and generates $331.26 million in revenue each year. The company earns $-79.06 million in net income (profit) each year or ($3.730010) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

Tabula Rasa HealthCare employs 1,602 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at (866) 648-2767 or via email at [email protected].

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.